David Low

Stock Analyst at JP Morgan

(1.22)
# 2,612
Out of 4,479 analysts
10
Total ratings
50%
Success rate
1.95%
Average return
Main Sectors:

1 Stocks

ResMed
Jan 9, 2024
Maintains: Overweight
Price Target: $160$195
Current: $186.94
Upside: +4.31%